Nine Point Two Capital LLC Abb Vie Inc. Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
A detailed history of Nine Point Two Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Nine Point Two Capital LLC holds 3,970 shares of ABBV stock, worth $773,316. This represents 0.24% of its overall portfolio holdings.
Number of Shares
3,970
Previous 3,970
-0.0%
Holding current value
$773,316
Previous $591,000
4.06%
% of portfolio
0.24%
Previous 0.24%
Shares
4 transactions
Others Institutions Holding ABBV
# of Institutions
3,694Shares Held
1.27BCall Options Held
13MPut Options Held
9.79M-
Vanguard Group Inc Valley Forge, PA171MShares$33.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.2 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.4 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.52 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $344B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...